PediCAP trial: Optimising treatment for children with severe community-acquired pneumonia

Children with community-acquired pneumonia are usually treated with an injectable antibiotic for five days. This often means staying in hospital for the full treatment period, even when they are well enough to go home earlier. The PediCAP trial tested a new approach designed to help children return home sooner while continuing to receive safe and effective care. In this episode, PediCAP team members Hilda Mujuru, Julia Bielicki and Michelle Clements discuss why the trial was needed, explain its innovative ROCI trial design, and share the results and what they mean for children, families and healthcare professionals. More information about PediCAP: https://www.innovative-ctu.ucl.ac.uk/studies/all-studies/p/pedicap/ For questions or feedback on the podcast, message us at mrcctu.engage@ucl.ac.uk As a listener, your opinion is very valuable to us. Please help us to improve the podcast in future by filling in this short survey: forms.office.com/e/PjfjQ5Mn6g